Cargando…

Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series

The COVID-19 pandemic has resulted in widespread use of complementary and alternative medicines. Tinospora cordifolia is a widely grown shrub which has been commonly used in India’s traditional system of Ayurveda for its immune booster properties and has been extensively used as prophylaxis against...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagral, Aabha, Adhyaru, Kunal, Rudra, Omkar S., Gharat, Amit, Bhandare, Sonal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252698/
https://www.ncbi.nlm.nih.gov/pubmed/34230786
http://dx.doi.org/10.1016/j.jceh.2021.06.021
_version_ 1783717353822879744
author Nagral, Aabha
Adhyaru, Kunal
Rudra, Omkar S.
Gharat, Amit
Bhandare, Sonal
author_facet Nagral, Aabha
Adhyaru, Kunal
Rudra, Omkar S.
Gharat, Amit
Bhandare, Sonal
author_sort Nagral, Aabha
collection PubMed
description The COVID-19 pandemic has resulted in widespread use of complementary and alternative medicines. Tinospora cordifolia is a widely grown shrub which has been commonly used in India’s traditional system of Ayurveda for its immune booster properties and has been extensively used as prophylaxis against COVID-19. Six patients (4 women, 2 men) with a median (IQR) age of 55 years (45–56) and with an history of Tinospora cordifolia consumption presented with symptoms of acute hepatitis during the study period of 4 months in the COVID-19 pandemic. The median (IQR) duration of Tinospora cordifolia consumption was 90 days (21–210). The median (IQR) peak bilirubin and AST were 17.5 mg/dl (12.2–24.9) and 1350 IU/ml (1099-1773), respectively. The patients had either a definite (n = 4) or probable (n = 2) revised autoimmune hepatitis score with an autoimmune pattern of drug-induced liver injury on biopsy. Four of these patients (all women) had underlying silent chronic liver disease of possible autoimmune etiology associated with other autoimmune diseases – hypothyroidism and type 2 diabetes mellitus. One of the three patients treated with steroids decompensated on steroid tapering. The other five patients had resolution of symptoms, liver profile, and autoimmune serological markers on drug withdrawal/continuing steroid treatment. The median (IQR) time to resolution from discontinuing the herb was 86.5 days (53-111). Tinospora cordifolia consumption seems to induce an autoimmune-like hepatitis or unmask an underlying autoimmune chronic liver disease, which may support its immune stimulant mechanism. However, the same mechanism can cause significant liver toxicity, and we recommend that caution be exercised in the use of this herb, especially in those predisposed to autoimmune disorders. Besides, in patients presenting with acute hepatitis, even in the presence of autoimmune markers, a detailed complementary and alternative medicine history needs to be elicited.
format Online
Article
Text
id pubmed-8252698
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82526982021-07-02 Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series Nagral, Aabha Adhyaru, Kunal Rudra, Omkar S. Gharat, Amit Bhandare, Sonal J Clin Exp Hepatol Case Report The COVID-19 pandemic has resulted in widespread use of complementary and alternative medicines. Tinospora cordifolia is a widely grown shrub which has been commonly used in India’s traditional system of Ayurveda for its immune booster properties and has been extensively used as prophylaxis against COVID-19. Six patients (4 women, 2 men) with a median (IQR) age of 55 years (45–56) and with an history of Tinospora cordifolia consumption presented with symptoms of acute hepatitis during the study period of 4 months in the COVID-19 pandemic. The median (IQR) duration of Tinospora cordifolia consumption was 90 days (21–210). The median (IQR) peak bilirubin and AST were 17.5 mg/dl (12.2–24.9) and 1350 IU/ml (1099-1773), respectively. The patients had either a definite (n = 4) or probable (n = 2) revised autoimmune hepatitis score with an autoimmune pattern of drug-induced liver injury on biopsy. Four of these patients (all women) had underlying silent chronic liver disease of possible autoimmune etiology associated with other autoimmune diseases – hypothyroidism and type 2 diabetes mellitus. One of the three patients treated with steroids decompensated on steroid tapering. The other five patients had resolution of symptoms, liver profile, and autoimmune serological markers on drug withdrawal/continuing steroid treatment. The median (IQR) time to resolution from discontinuing the herb was 86.5 days (53-111). Tinospora cordifolia consumption seems to induce an autoimmune-like hepatitis or unmask an underlying autoimmune chronic liver disease, which may support its immune stimulant mechanism. However, the same mechanism can cause significant liver toxicity, and we recommend that caution be exercised in the use of this herb, especially in those predisposed to autoimmune disorders. Besides, in patients presenting with acute hepatitis, even in the presence of autoimmune markers, a detailed complementary and alternative medicine history needs to be elicited. Elsevier 2021 2021-07-02 /pmc/articles/PMC8252698/ /pubmed/34230786 http://dx.doi.org/10.1016/j.jceh.2021.06.021 Text en © 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.
spellingShingle Case Report
Nagral, Aabha
Adhyaru, Kunal
Rudra, Omkar S.
Gharat, Amit
Bhandare, Sonal
Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series
title Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series
title_full Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series
title_fullStr Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series
title_full_unstemmed Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series
title_short Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series
title_sort herbal immune booster-induced liver injury in the covid-19 pandemic - a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252698/
https://www.ncbi.nlm.nih.gov/pubmed/34230786
http://dx.doi.org/10.1016/j.jceh.2021.06.021
work_keys_str_mv AT nagralaabha herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries
AT adhyarukunal herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries
AT rudraomkars herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries
AT gharatamit herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries
AT bhandaresonal herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries